STRO
Sutro Biopharma
15.40$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 303.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 14.6 | 53.6 | 6.3 | 5.7 | 4.1 | 6.0 | 57.3 | 61.7 | 83.6 | 187.4 | 208.4 | 12.5 | 14.7 | 11.1 | 7.2 | 4.6 | 4.2 | 6.8 | 3.6 | 5.0 | 4.4 | 1.7 | 2.3 | 1.4 | 1.8 | 2.4 | 0.8 | 0.6 | 0.7 | 1.0 | 3.3 | 12.0 | |
| – | – | – | – | – | – | – | – | 15.6 | 2.0 | 2.2 | 1.9 | 2.6 | 28.8 | 12.0 | 15.7 | 24.1 | 34.1 | 2.8 | 3.1 | 2.7 | 1.7 | 1.2 | 1.3 | 2.1 | 1.5 | 1.8 | 1.9 | 1.8 | 3.6 | 1.5 | 2.6 | 3.3 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 13.5 | 50.7 | 6.0 | 5.5 | 4.1 | 6.1 | 57.0 | 60.7 | 82.9 | 183.3 | 207.8 | 12.0 | 14.6 | 11.0 | 7.1 | 3.5 | 3.1 | 6.5 | 3.2 | 1.2 | 3.0 | 1.3 | 1.9 | 0.9 | 0.7 | -0.6 | -0.7 | 0.0 | 0.2 | 0.5 | 2.6 | 11.0 | |
| – | – | – | – | – | – | – | 27.7 | 185.0 | 42.9 | 65.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 3.6% | 0.5% | 2.3% | 1.5% | -28.7% | -26.8% | -2.9% | -2.7% | -1.8% | -0.9% | -0.8% | -9.9% | -10.7% | -14.1% | -26.5% | -39.2% | -0.4% | -0.9% | -10.9% | -20.0% | -73.5% | -44.2% | -34.0% | -33.0% | -38.0% | -131.0% | -367.5% | -419.7% | -304.9% | -179.7% | -46.7% | -26.5% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | 22.7% | -0.3% | -22.7% | -60.1% | -121.9% | -41.2% | -36.6% | -27.5% | -24.7% | -53.5% | -64.9% | -72.0% | -56.5% | -80.1% | -63.1% | -30.8% | -63.4% | -68.7% | -110.5% | -62.7% | 14.2% | -7.9% | 42.1% | -49.0% | -74.2% | 72.9% | 71.9% | 97.9% | 97.8% | 94.3% | 97.3% | 100.0% | 100.0% | 100.0% | 98.7% | 97.2% | |
| – | – | – | -2.6% | -37.2% | -69.4% | -121.2% | -210.1% | -96.9% | -96.4% | -89.8% | -87.0% | -129.8% | -146.3% | -157.0% | -133.3% | -166.3% | -141.1% | -93.4% | -148.4% | -159.2% | -223.4% | -241.2% | -164.4% | -190.3% | -177.1% | -279.3% | -373.4% | -58.1% | -67.3% | -62.7% | -80.8% | -384.3% | -376.9% | -196.3% | -175.7% | -150.2% | -115.5% | -309.9% | |
| – | – | – | -2.5% | -38.1% | -71.3% | -122.1% | -210.4% | -91.9% | -90.9% | -86.3% | -84.0% | -130.4% | -148.1% | -43.3% | 27.6% | -75.2% | -85.4% | -114.7% | -213.4% | -170.6% | -215.2% | -252.3% | -175.9% | -175.9% | -174.6% | -250.9% | -354.5% | -69.5% | -74.6% | -73.5% | -77.0% | -366.6% | -369.1% | -199.8% | -205.2% | -186.5% | -154.2% | -395.2% | |
| – | – | – | – | -78.1% | -93.7% | -114.3% | 52.9% | 29.0% | 14.7% | 8.6% | -118.8% | -160.3% | -163.8% | -163.6% | -152.2% | -175.4% | -175.7% | -123.0% | -156.9% | -156.8% | -190.2% | -180.0% | -1.7% | -6.4% | -39.5% | -100.0% | -320.3% | -75.4% | -77.4% | -45.9% | -67.8% | -313.7% | -298.8% | -241.2% | -213.1% | -174.6% | -152.7% | -318.6% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | -26.8% | -28.7% | -33.3% | -38.6% | -57.0% | -74.4% | -8.4% | 5.2% | -9.7% | -14.0% | -25.7% | -44.8% | -41.8% | -51.9% | -64.2% | -53.4% | -54.9% | -70.2% | -92.2% | -153.5% | -71.4% | -117.3% | -81.8% | -111.4% | -510.0% | – | – | – | – | – | – | |
| – | – | – | – | -48.3% | -67.0% | -89.3% | -33.9% | -15.8% | -18.5% | -21.1% | -24.7% | -35.6% | -39.7% | -6.3% | 4.1% | -8.2% | -12.0% | -21.9% | -34.2% | -30.9% | -37.6% | -34.8% | -30.6% | -29.3% | -36.4% | -30.7% | -39.9% | -22.7% | -28.5% | -25.4% | -27.4% | -58.7% | -76.3% | -79.5% | -103.4% | -109.9% | -63.5% | -92.9% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -7.5 | 37 | -11 | -27 | -111 | -12 | -6.6 | -0.6 | 4.9 | -16 | -37 | -34 | -173 | -27 | -32 | -4.3 | -4.3 | -2.6 | -56 | -75 | -22 | -31 | -213 | -69 | -59 | -59 | -84 | -167 | -183 | -98 | -56 | -58 | -50 | -66 | -48 | |
| 16.8% | – | – | – | -267.4% | -10.6% | -292.2% | -97.5% | 58.9% | 64.6% | 63.3% | 64.0% | 62.5% | 53.3% | 74.5% | 79.5% | 84.3% | 85.7% | 85.5% | 76.3% | 74.0% | 72.6% | 54.2% | 57.3% | 53.3% | 51.8% | 33.3% | 26.0% | 31.8% | 24.3% | 31.1% | 24.6% | 11.5% | -8.0% | -12.2% | -41.6% | -76.2% | -27.6% | -53.1% | |
| – | – | – | – | – | – | – | – | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | – | – | – | – | – | – | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -3.78 | -28.14 | -43.26 | -18.21 | -21.54 | -1.54 | -16.41 | -17.35 | -18.50 | -24.03 | -2.63 | -0.55 | 0.33 | -0.87 | -0.93 | -17.11 | -27.50 | -22.86 | -24.58 | -28.57 | -23.45 | -20.99 | -22.16 | -23.64 | -28.46 | -17.50 | -18.70 | -15.32 | -15.11 | -27.56 | -29.51 | -24.67 | -25.54 | -22.26 | -11.74 | -10.90 | |
| – | – | – | 153.53 | 73.94 | 60.64 | 14.91 | 10.24 | 1.68 | 18.04 | 20.10 | 22.01 | 18.42 | 1.78 | 1.27 | 1.21 | 1.16 | 1.09 | 14.92 | 12.89 | 13.40 | 11.42 | 11.32 | 13.33 | 11.93 | 12.69 | 9.42 | 8.03 | 25.20 | 25.07 | 20.85 | 19.62 | 7.52 | 7.99 | 12.35 | 12.45 | 11.94 | 7.61 | 2.76 | |
| – | 290.05 | – | – | -155.77 | -6.84 | -59.58 | -61.97 | 5.75 | 57.17 | 52.15 | 47.90 | 42.15 | 3.54 | 6.51 | 6.44 | 9.00 | 6.69 | 66.68 | 61.43 | 54.71 | 47.39 | 44.52 | 43.89 | 38.22 | 31.57 | 25.64 | 18.54 | 24.53 | 15.95 | 18.74 | 13.56 | 5.40 | -3.11 | -3.80 | -10.28 | -15.43 | -5.11 | -6.23 | |
| – | – | – | – | -57.72 | -56.83 | -17.04 | 5.42 | 0.49 | 2.66 | 1.73 | -26.16 | -29.53 | -2.91 | -2.07 | -1.84 | -2.03 | -1.92 | -18.36 | -20.23 | -21.01 | -21.72 | -20.38 | -0.23 | -0.76 | -5.01 | -9.42 | -25.71 | -19.00 | -19.39 | -9.56 | -13.31 | -23.58 | -23.89 | -29.80 | -26.52 | -20.84 | -11.63 | -8.79 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.